Utang jangka cendhak marang modal Twist Bioscience (TWST)

Current price action for Twist Bioscience (TWST) demonstrates metrics at 0.04, while the business relies on stable demand from scientists for biomaterials, ensuring resilience against market volatility. Expanding silicon plant capacities allows the company to scale the production of synthetic chains. Laboratory efficiency is guaranteed through the digitalization of orders and the rapid transportation of finished genetic products.

Twist Bioscience's leadership in high-precision DNA synthesis requires significant R&D investment, making the management of current liabilities critical. The ratio of short-term borrowings to equity measures the proportion of debt maturing within one year, allowing the short-term debt-to-equity ratio trend to assess liquidity risks and the sustainability of the issuer's financial leverage.